Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia.
Li J, Xue L, Hao H, Han Y, Yang J, Luo J.
Oncol Rep. 2012 Feb;27(2):461-6. doi: 10.3892/or.2011.1502. Epub 2011 Oct 12.
Related citations
Acacetin induces apoptosis in human T cell leukemia Jurkat cells via activation of a caspase cascade.
Watanabe K, Kanno S, Tomizawa A, Yomogida S, Ishikawa M.
Oncol Rep. 2012 Jan;27(1):204-9. doi: 10.3892/or.2011.1498. Epub 2011 Oct 12.
Free LIF receptor α-chain distal cytoplasmic motifs enhance Jak2-independent STAT3 phosphorylation and induce differentiation in HL-60 cells.
Sun Q, Wang J, Xiong J, Yang L, Liu H.
Oncol Rep. 2011 Aug;26(2):399-404. doi: 10.3892/or.2011.1289. Epub 2011 Apr 29.
Induction of apoptosis by ethanol extract of Prunus mume in U937 human leukemia cells through activation of caspases.
Park C, Jin CY, Kim GY, Jeong YK, Kim WJ, Choi YH.
Oncol Rep. 2011 Oct;26(4):987-93. doi: 10.3892/or.2011.1363. Epub 2011 Jun 27.
Survivin and P-glycoprotein are associated and highly expressed in late phase chronic myeloid leukemia.
Reis FR, Vasconcelos FC, Pereira DL, Moellman-Coelho A, Silva KL, Maia RC.
Oncol Rep. 2011 Aug;26(2):471-8. doi: 10.3892/or.2011.1296. Epub 2011 May 4.
Immunogenic apoptosis in human acute myeloid leukemia (AML): primary human AML cells expose calreticulin and release heat shock protein (HSP) 70 and HSP90 during apoptosis.
Fredly H, Ersvær E, Gjertsen BT, Bruserud O.
Oncol Rep. 2011 Jun;25(6):1549-56. doi: 10.3892/or.2011.1229. Epub 2011 Mar 22.
Survivin overexpression correlates with an apoptosis-resistant phenotype in chronic myeloid leukemia cells.
Nestal de Moraes G, Silva KL, Vasconcelos FC, Maia RC.
Oncol Rep. 2011 Jun;25(6):1613-9. doi: 10.3892/or.2011.1224. Epub 2011 Mar 22.
Growth of chronic myeloid leukemia cells is inhibited by infection with Ad-SH2-HA adenovirus that disrupts Grb2-Bcr-Abl complexes.
Peng Z, Luo HW, Yuan Y, Shi J, Huang SF, Li CL, Cao WX, Huang ZG, Feng WL.
Oncol Rep. 2011 May;25(5):1381-8. doi: 10.3892/or.2011.1197. Epub 2011 Mar 1.
WNT5A expression is regulated by the status of its promoter methylation in leukaemia and can inhibit leukemic cell malignant proliferation.
Deng G, Li ZQ, Zhao C, Yuan Y, Niu CC, Zhao C, Pan J, Si WK.
Oncol Rep. 2011 Feb;25(2):367-76. doi: 10.3892/or.2010.1108. Epub 2010 Dec 14.
Terpenic subfraction of Pterodon pubescens induces apoptosis of K562 leukemic cells by modulating gene expression.
Pereira MF, Martino T, Dalmau SR, Albano RM, Férézou JP, Costa SS, Coelho MG, Sabino KG.
Oncol Rep. 2011 Jan;25(1):215-21.
Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells.
Lee WJ, Chen YR, Tseng TH.
Oncol Rep. 2011 Feb;25(2):583-91. doi: 10.3892/or.2010.1097. Epub 2010 Dec 10.
Screening of novel immunostimulatory CpG ODNs and their anti-leukemic effects as immunoadjuvants of tumor vaccines in murine acute lymphoblastic leukemia.
Wang J, Zhang W, He A, Zhao W, Cao X.
Oncol Rep. 2011 Feb;25(2):519-29. doi: 10.3892/or.2010.1093. Epub 2010 Dec 10.
Thalidomide enhances cyclophosphamide and dexamethasone-mediated cytotoxicity towards cultured chronic lymphocytic leukaemia cells.
Pointon JC, Eagle G, Bailey J, Evans P, Allsup D, Greenman J.
Oncol Rep. 2010 Nov;24(5):1315-21.
Natural killer-like T CD3+/CD16+CD56+ cells in chronic lymphocytic leukemia: intracellular cytokine expression and relationship with clinical outcome.
Bojarska-Junak A, Hus I, Sieklucka M, Wasik-Szczepanek E, Mazurkiewicz T, Polak P, Dmoszynska A, Rolinski J.
Oncol Rep. 2010 Sep;24(3):803-10.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on